[logo] HealthTree Foundation
more_vert

Education, community and tools to navigate your disease

Lifetime support and education

Your brighter tomorrow starts today with free patient education resources

Learn more with 101 patient guides

Meaningful patient-to-patient connections

Find a community of multiple myeloma patients who care and are just like you

Lisa Hatfield image
HealthTree Coach Icon

Lisa Hatfield

multiple myeloma coach since 2024

Radiation, surgery, chemo. In that order. It was decided while we sat in a sterile room at MD Anderson with my radiation oncologist who was speaking with my neurosurgeon, while both examined the images of my spine. Damaged by myeloma. A blood cancer. I was numb. A plasmacytoma was asserting itself and growing dangerously close to my spinal cord. The debate: radiation first vs surgery first. Chemo wasn’t even on the table. My spine had to be stabilized. I wanted to talk about the cancer and all the other lesions and malignant cells in my bone marrow. But that would have to wait. That was May of 2018. We left our daughters with family, on Mother’s Day. MD Anderson asked us to commit to being there a week. We were there a month. I returned home with a walker, a lot of pain, some fear, and a chemo cocktail recipe written by my medical oncologist (who I was finally able to meet). My chemo was administered in my hometown. Kyprolis, Revlimid, and dex. Kyprolis was not approved at that time for first-line therapy, but my myeloma specialist at MDA was able to get approval for me to receive it at my local cancer center. 6 months of KRd followed, while still recovering from major spine surgery. With a short break from KRD, I had stem cells harvested. And frozen. I opted to delay autologous stem cell transplant (ASCT), as I was still recovering from surgery and did not want to be away from our kids for another extended period. Revlimid was not my friend. Following the 6 months of KRD, I continued Revlimid maintenance for 4 years until the cumulative effects altered by quality of life. (Still dealing with those, even after discontinuing Rev almost two years ago). Most recent Clonoseq bone marrow biopsy showed 572 cells per million (my daughters’ birthdays and my anniversary date used to be the most important numbers to me… this “572” has crept a little too close to the space of those important numbers…I guess that’s how myeloma is). All of my decisions have been made with the two myeloma specialists I see on a regular basis. I am a HUGE advocate for expert opinions with myeloma. And… I believe that myeloma specialists are extraordinary people (mine are incredible human beings). I love good coffee, good chocolate, good books, good conversations, and good, genuine connections. I believe that connecting with others is a critical piece in our myeloma journey and enhancing our quality of life. Not every day will be good, but every day can have hope. I hope I can be a soft but strong support for others and a giver of hope.

View Coach

Powerful Patient Data Portal

HealthTree Cure Hub helps you navigate your disease by tracking your labs and so much more

HealthTree Cure Hub Program demo image

You can help advance multiple myeloma research

In HealthTree Cure Hub, your data and researchers' expertise combine to shorten the breakthrough time from years to days; every second counts

HealthTree Cure Hub Surveys demo image

Get involved today!

At HealthTree we're on a mission to accelerate cures. Here's how you can help:

Join a local chapter

Our chapters are designed to empower and activate patients and caregivers who are committed to finding a cure. In partnership with HealthTree, chapters provide support, education, and raise revenue to cure diseases

Find a community arrow_forward

Donate to HealthTree, a nonprofit organization

Our core mission is to provide as many patient resources possible to any and all underserved communities in the US and eventually worldwide.

Donate to HealthTree arrow_forward

Thank you to our multiple myeloma funding partners

Free patient resources made possible with

Amgen logo
Sanofi logo
Adaptive logo
Pfizer logo
Kite logo

Together we care.

Together we cure.

3x Faster.

Join our year-end match and help us reach $2 million for blood cancer research!